Repurposing zileuton as a depression drug using an ai and in vitro approach

HIGHLIGHTS

• who: Norwin Kubick and collaborators from the Department of Biochemistry and Molecular Cell Biology (IBMZ), University Medical Center and Genetics, Polish Academy of Science, Post˛epu A, Garbatka, Poland have published the research: Repurposing Zileuton as a Depression Drug Using an AI and In Vitro Approach, in the Journal: Molecules 2020, 2155 of /2020/
• what: The aim of this study is to identify putative compounds that are capable of enhancing the anti-inflammatory response in depression. The authors focused on Nrf2 activation drug repurposing using an AI approach in Google Colab
• how: For . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.